Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05466981 · ClinicalTrials.gov registry record · NA
HCV-Smoking Cessation Study
A NA study of Smoking Cessation and Hepatitis C, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05466981: Completed NA study of Smoking Cessation and Hepatitis C, sponsored by Prisma Health-Upstate.
NCT05466981 is a NA study of Smoking Cessation and Hepatitis C that has completed, run by Prisma Health-Upstate. The registered enrollment target is 10 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05466981, a NA study of Smoking Cessation and Hepatitis C, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
A 12-week study for patients who are being treated for Hepatitis C and would like to quit smoking. During the 12 weeks of Hepatitis C treatment, the research team will have counseling sessions with the participants to discuss challenges related to Hepatitis C and smoking.
Primary Outcome
We will track the number of cigarettes the participant smokes per day at each weekly visit, then compare the CPD at baseline during week 0 to the end of treatment at week 12.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Counseling
Study Locations (1)
South Carolina
- Prisma Health Internal Medicine Clinic - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-11-23 |
| Est. Completion | 2021-11-11 |
| Phase | NA |
What the finished NCT05466981 record still lists
NCT05466981 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Counseling is the first listed.
NCT05466981 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05466981 about?
NCT05466981 is a clinical study titled "HCV-Smoking Cessation Study". A 12-week study for patients who are being treated for Hepatitis C and would like to quit smoking. During the 12 weeks of Hepatitis C treatment, the research team will have counseling sessions with the participants to discuss challenges related to Hepatitis C and smoking.
What is the current status of trial NCT05466981?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-11-23. Estimated completion is 2021-11-11.
What conditions does trial NCT05466981 study?
This clinical trial studies the following conditions: Smoking Cessation, Hepatitis C.
What interventions are being tested in trial NCT05466981?
The interventions under investigation include: Cognitive Behavioral Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT05466981?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05466981 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05466981's enrollment target sits among peer trials
10 185th of 188 higher than 3 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI